% | $
Quotes you view appear here for quick access.

Catalyst Pharmaceuticals, Inc. Message Board

  • slebens slebens Oct 19, 2013 11:04 AM Flag

    Giving medication away?

    Neither the AF article nor any postings here have yet asked what I think is a glaring question: how can Jacobus afford to give 3,4 DAP away for free for 20+ years? Unless that's explained, none of this makes any sense.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I can only speculate that Jacobus are receiving some sort of funding from these research programs to continue to manufacture the drug. The other question you might want to ask is why are these researchers even studying this drug if they don't think that they're going to gain anything from it? Is it purely because of altruistic cause or scientific curiosity? If that's your conclusion, then you might be a little to naive. Remember that nothing in this world is free. Somebody always has to pay for it.

    • Jacobus has other meds that are profitable and because of the small amount of LEMs patients they can afford to do it. They did not want to go to the expense of the trial but because they know many of us on a personal basis they know what would happen if we could not get DAP. I know it is hard to believe that there are still some company's that have no stock holders or board members to answer to that really care about the patient.Fred

      • 1 Reply to ohfredoh
      • I could see offering it at cost. However, that's not allowable under FDA rules. No, I'm still not satisfied that Jacobus can afford to run a production line of 3,4 DAP for over 12 years with no revenue coming in from the drug. That also raises the question of funding for the phase II and III trials to get FDA approval for 3,4 DAP. How do they get the money for that? And when it's all spent, they're just going to continue to give it away for free? This just doesn't add up to me.

        Sentiment: Hold

    • just like anything free, government pays them from your taxes

    • Its is mandatory when the drug is not officially approved as McEnany points out in his answer to questions put to him by AF in the article. David and Laura Jacobus are not doing so out of altruism.

1.08+0.02(+1.89%)Aug 25 4:00 PMEDT